Search

everythinglearnresearchcommunity

for

Search:↓

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Individualized treatment improves symptoms and quality of life for women with PCOS.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Compression therapy improved ankle movement, reduced leg swelling, and lessened pain in patients with venous leg ulcers.

Effective epilepsy management involves accurate diagnosis, understanding seizure types, identifying causes, and choosing the right treatment.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Facebook groups help patients using scalp cooling therapy by offering support, advice, and product recommendations.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

More severe alopecia areata can lower quality of life.

Low ferritin levels are linked to increased hair loss; no link found between vitamin B12, TSH levels, and hair loss.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Sweat gland development involves two unique skin cell programs and a temporary skin environment.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.